enGene Holdings Inc.

Ownership Transactions Reported by 23 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1.04M	95.2%	$7.74	+$8.07M
Sells	1	-52.5K	4.8%	$15.00	-$788K
Net	+1	+990K	90.4%		+$7.28M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Forbion Growth Opportunities Fund I Cooperatief U.A.	10%+ Owner	$60.5M	+$8.01M	+15.3%	Oct 30, 2024
Fonds De Solidarite Des Travailleurs Du Quebec	10%+ Owner	$45.5M	-$788K	-1.7%	Apr 18, 2024
Lumira Capital Investment Management Inc.	10%+ Owner	$38.5M			Feb 20, 2024
Gerald A. Brunk	Director	$2.39M			Jun 15, 2024
Anthony T. Cheung	Chief Scientific Officer	$1.03M			Oct 21, 2024
Ronald Harold Wilfred Cooper	Chief Executive Officer, Director	$57K	+$57K		Sep 27, 2024
Richard M. Glickman	Director	$22K			Jun 15, 2024
Richard P. Bryce	Chief Medical Officer				Nov 30, 2023
Forbion Growth Sponsor FEAC I B.V.	10%+ Owner				Oct 31, 2023
James C. Sullivan	Chief Scientific Officer				Oct 31, 2023
Forbion Capital Fund III Cooperatief U.A.	10%+ Owner				Oct 31, 2023
D. Ryan Daws	Chief Financial Officer				Nov 30, 2023
Lota S. Zoth	Director				Jun 15, 2024
Alexander Julian Nichols	Pres. & Chief Operating Ofc.				Oct 31, 2023
Jasper Bos	Director				Jun 15, 2024
Lee Giguere	Chief Legal Ofc. and Corp Secy				Mar 15, 2024
Alexandre Jean-Rene Erwan Grassin	Int. Chief Financial Officer				Oct 31, 2023
Wouter Joustra	Director				Jun 15, 2024
Paul J. Hastings	Director				Jun 15, 2024
Raj Som Pruthi	Chief Medical Officer				Jul 24, 2024
Joan Connolly	Chief Technology Officer				Oct 21, 2024
Bvf Partners L P/Il	10%+ Owner				Oct 31, 2023
Jason D. Hanson	Chief Executive Officer, Director				Oct 31, 2023

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.